Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;

A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales; Rafael Cáliz; Susana Aceituno; Miriam Prades; Carles Blanch;

Psoriasis inducida por terapia biológica Lydia Montolio Chiva; Àngels Martínez Ferrer; Almudena Mateu Puchades; Cristina Campos Fernández; Javier Narváez Garcia; Juan José Alegre Sancho;